Searched for
LAURUS LABS IPO
Virupaksha Organics files draft papers with Sebi for Rs 740 crore IPOPharmaceutical company Virupaksha Organics has filed preliminary papers with capital markets regulator Sebi to raise Rs 740 crore through a...
Mankind Pharma plans $1 billion IPO, hires bankersIn the proposed offer for sale, existing investors ChrysCapital will sell about 1% stake, Capital International will sell another 6% while ...
IIFL, GMO, WhiteOak, Malabar invest Rs 200 crore in Laxmi Organic pre-IPO roundIn 2012, International Finance Corporation took a 10.05% equity stake in the company at face value of Rs 10 each which the company bought b...
Laxmi Organics plans to go public, files draft papers for Rs 800 crore IPOThe IPO is a fresh issuance aggregating to Rs 500 crore and an offer for sale of face value of Rs 2 each by the promoter selling shareholde...
India's largest pharma IPO set to hit marketThis will be the largest IPO by a pharmaceutical company in India. The biggest IPO till date in the sector was from Eris Lifesciences, whic...
Chemcon Speciality IPO: Issue size, price band & other key detailsThe firm is India’s largest manufacturer of specialised chemicals, such as Hexamethyldisilazane / Hexamethyldisilane (HMDS) and Chloromethy...
Neogen Chem looks pricey, better to enter after listingThe IPO appears to be richly valued when compared with listed peers.
Midcap pharma stocks could be a worthwhile betHDFC Securities in a note said it met with the management of some emerging formulations players such as Granules India and Laurus Labs.
Laurus Labs hopes better profits in Q4 with lower interest outgo after debt retirementThe company repaid long term loans of Rs 226.3 crore from the proceeds of Rs 1,332 crore raised through an initial public offering (IPO) in...
Laurus Labs debuts at Rs 490 on BSE, 14.5% premium to issue priceThe drugmaker sold its Rs 1,332 crore initial public offering (IPO) between December 6 and December 8, which was subscribed 4.52 times.
Laurus Labs shares to list on bourses on December 19Kotak Mahindra Capital Company, Citigroup Global Markets India, Jefferies India and SBI Capital Markets were the book running lead managers...
Laurus Labs IPO gets subscribed 4.5 times on day 3The quota limit for qualified institutional buyers (QIB) category was subscribed 10.54 times, the retail individual investor (RII) category...
Laurus Labs IPO subscribed 61% on Day 2, QIB portion oversubscribedThe company intends to utilise the proceeds from the sale of fresh shares in the IPO to pre-pay term loans and for other general corporate ...
Laurus Labs IPO subscribed 28 per cent on Day 1; 10 things you must knowThe issue received bids for 62,09,420 shares as against 2,19,11,308 on offer, data available with the stock exchanges till 5 pm showed.
Post IPO our debt would be around 750 crore: Ravi Kumar VV, Executive Director & CFO, Laurus LabsAs on 30th September, we have at debt of about 1100 crore and then we already repaid about 140 crore, so current debt is about 960 and out ...
IPO watch: Laurus issue opens today, good business model may make it a hitThe company is raising Rs 1,330 crore in the primary market. Proceeds of Rs 225 crore from the issue will be used to reduce debt on the com...
Rs 1,332 cr Laurus Labs IPO opens tomorrow, should you buy?Brokerage ICICI Securities believe at the upper end of the price band the stock is fairly priced, after considering the growth prospects, p...
Laurus Labs' Rs 1,332-crore IPO to hit market on TuesdayThe Hyderabad-based company plans to utilise the net proceeds from the fresh issue towards pre-payment of term loans and general corporate ...
Laurus Labs fixes IPO price band at Rs 426-428 a piece; issue opens on Dec 6The issue consists of an offer for sale (OFS) of 24,107,440 equity shares by existing shareholders Aptuit, Bluewater, FIL Capital Managemen...
Laurus Labs plans Rs 750-1,000 crore IP0; Hires Citi, Kotak, JefferiesThe company is expected to dilute up to 25% stake in the share sale, which will value the company at about Rs 4,000 crore, they said.